Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 7-Day Trial for You or Your Team.

Learn More →

The EGFR as a target for anticancer therapy--focus on cetuximab.

The EGFR as a target for anticancer therapy--focus on cetuximab. http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png European Journal of Cancer Pubmed

The EGFR as a target for anticancer therapy--focus on cetuximab.

Baselga, J
European Journal of Cancer , Volume 37 Suppl 4: 7 – Dec 7, 2001
Download PDF

The EGFR as a target for anticancer therapy--focus on cetuximab.

Baselga, J
European Journal of Cancer , Volume 37 Suppl 4: 7 – Dec 7, 2001

Loading next page...
 
/lp/pubmed/the-egfr-as-a-target-for-anticancer-therapy-focus-on-cetuximab-hGeEJEJSYH

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

ISSN
0959-8049
DOI
10.1016/s0959-8049(01)00233-7
pmid
11597400

Abstract

Journal

European Journal of Cancer – Pubmed

Published: Dec 7, 2001

There are no references for this article.